SMARCA2 and thyroid cancer: We found that overexpression of SETMAR could promote the protein and mRNA expression of SMARCA2 in thyroid cancer cells, while inhibition of SETMAR had the opposite effect (Figure 4F; Figure S4C, Supporting Information).